Medicare Rule to Cut Outpatient Drug Costs by 2027

CMS finalized changes lowering patient charges and Medicare spending on certain drugs in hospital outpatient departments.

Updated on Nov. 13, 2026 in Healthcare

Isometric editorial illustration of a row of unlabeled amber medication vials on a steel tray in a bare clinical room, evoking Medicare drug pricing changes.
CMS finalized a rule lowering Medicare patient charges and Medicare spending on certain drugs given in hospital outpatient departments, starting in 2027. AI Illustration. Upload story photo >

Live Poll

Do you think healthcare costs are getting better or worse for you?

The Centers for Medicare and Medicaid Services has finalized a rule that reduces Medicare patient charges and Medicare spending on certain drugs in hospital outpatient departments, taking effect in 2027. The change applies to Original Medicare beneficiaries receiving qualifying medications in those settings.

Why it matters

The changes are designed to lower charges for patients and reduce the amount Medicare pays for certain drugs as part of a broader overhaul of hospital outpatient payments. Discounts will be passed on to patients and taxpayers under the updated legislation.

CMS projects a $1.1 billion reduction in patients' combined costs and a $4.35 billion trim in Medicare spending over the next year, with individual patient savings capped at $900. These estimates are projections, and the rule does not take effect until 2027.

The players

Centers for Medicare and Medicaid Services

The federal agency that administers Medicare and finalized the outpatient drug payment rule.

Dr Mehmet Oz

A public official who leads the Centers for Medicare and Medicaid Services.

The details

The rule applies to Original Medicare beneficiaries who receive qualifying medications in hospital outpatient departments. It forms part of a broader overhaul of payments for hospital outpatient services.

Timeline

  1. 2027: New outpatient payment rule takes effect.

  2. Over the next year: CMS estimates $1.1 billion in patient savings and $4.35 billion in Medicare spending reductions.

Market Landscape

The rule extends the federal push to curb Medicare drug costs, following the Inflation Reduction Act's drug-price negotiation provisions. It targets hospital outpatient payments, a segment that has drawn scrutiny as part of a broader payment overhaul.

Patients receiving qualifying medications in hospital outpatient departments could see lower out-of-pocket charges once the rule takes effect in 2027. Original Medicare beneficiaries are the group directly affected by the change.

The takeaway

Medicare beneficiaries who use hospital outpatient drug services should watch for these changes ahead of the 2027 effective date. Lower patient charges and reduced program spending are the intended results of the rule.

Further reading

For related coverage, see Healthcare on Wisevoter.

Source note: This article includes information reported by The US Sun.

Live Poll

Do you think healthcare costs are getting better or worse for you?